Objectives: At the end of the talk the participants will have an understanding of the technology of cerebral oximetry, its clinical applications and impact on outcomes, currently available commercial devices and the limitations of cerebral oximtery.
Introduction:
Frans Jobsis first described the measurement of cerebral oxyhemoglobin content by a spectrophotometric technique in 1977. Although this was met with much enthusiasm, 30 years later, near infrared spectroscopy based cerebral oximeter still remains a monitor looking for its proper place in the pantheon of monitoring.
Technology of Cerebral oximetry: Light in the near-infrared (700-1300 nm) range has three important physical properties that make it useful for diagnostic assessment: it pentrates tissue; it is non-ionizing; and it is absorbed differentially by relevant chromophores depending on their oxygen-binding state. When nearinfrared light is emitted across a tissue (e.g. the brain) and detected at its exit, absorption of the light can be used to calculate chromophore concentration using variants of the Beer-Lambert equation. All optical spectrometers consist of the same basic components: a light source of a known intensity and wavelength; a light detector to measure the intensity of the light exiting the tissue; and a computer to translate the changes in light intensity to clinically useful information such as the concentrations of HbO2, Hb or oxidized cytochrome aa3.
When photons impinge on biological materials, their transmission depends on a combination of reflectance, scattering and absorption effects. A light source (light emitting diode or laser source) emits near-infrared light which passes through a "banana-shaped" reflectance path in the frontal cerebral cortex to two to three detectors placed 3-5 cm from the emitter. Absorption occurs at specific wavelengths, determined by the molecular properties of the material in the light path. Optical path length for reflected light is linearly related to the spacing between the transmission and receiving sites and so many of the NIRS measurement instruments place the transmitting diode and light detector several centimeters apart on the head. Although this spacing results in a measurable signal intensity, it affects the amount and depth of tissue monitored. On a practical level, the available instruments space their transmitting and receiving sites differently, thus measuring different quantities and depths of tissue which makes comparisons between instruments difficult.
Shallow arcs of light travel across skin and skull but do not penetrate the cerebral tissue. Deep arcs of light cross skin, skull, dura and cortex. Subtracting the absorbance measured in the narrow arc from that measured in the deep arc leaves absorbance that is due to intracerebral chromophores. This is one of the distinguishing characteristics of cerebral oximeters compared to pulse oximeters.
Cerebral oximeters use spatial resolution techniques to differentiate cortical from extracranial blood, whereas pulse oximeters differentiate pulsatile ( Conclusion: Despite the limitations of the technology and paucity of large studies showing a clear benefit we must adopt this technology and use it when we care for sick neonates or those with heart disease where detecting ongoing cerebral desaturation to ischemic levels in the face of arterial oxygen desaturation is otherwise impossible. Neurological outcome studies are expensive, take decades and by the time the results are available the damage may be long done.
